Product Information

DILTIAZEM 24H ER(XR) 120 MG CP is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.3196 per EA under NDC 70436019101. Its NADAC has been published 195 times since Nov 30, 2022.

FDA first approved this application on Aug 8, 2022. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DILTIAZEM 24H ER(XR) 120 MG CP

Diltiazem Hydrochloride
$0.3196per EA

Strength

120 mg/1

NDC

70436019101

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA216304

FDA Approved

8/8/2022

TE Code

AB2

On Market Since

9/5/2022

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for DILTIAZEM 24H ER(XR) 120 MG CP has been published 195 times since Nov 30, 2022, and over the history we have for it it has declined 25.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3196 per EA
All-time high$0.4672 (Aug 16, 2023)
All-time low$0.2531 (Nov 20, 2024)
52-week high$0.4103
52-week low$0.3049
Median price$0.3990
Average price$0.3902
Largest weekly change-45.5% (Nov 20, 2024)
Weeks tracked195
Tracking sinceNov 30, 2022

Price History

1W

+4.8%

1M

+4.5%

3M

+3.9%

6M

-13.2%

1Y

-22.1%

3Y

-31.6%

5Y

N/A

All

-25.4%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 72% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DILTIAZEM 24H ER(XR) 120 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24H ER(XR) 120 MG CP, manufactured by Slate Run Pharmaceuticals LLC, is $0.3196 per EA (NDC 70436019101), effective Aug 19, 2026.

How has the price of DILTIAZEM 24H ER(XR) 120 MG CP changed over time?

Over the history we have for it, the NADAC for DILTIAZEM 24H ER(XR) 120 MG CP has declined 25.4%. It has been tracked across 195 weekly CMS publications since Nov 30, 2022.

What are the highest and lowest recorded NADAC prices for DILTIAZEM 24H ER(XR) 120 MG CP?

Since Nov 30, 2022, the NADAC for DILTIAZEM 24H ER(XR) 120 MG CP has ranged from a low of $0.2531 (Nov 20, 2024) to a high of $0.4672 (Aug 16, 2023), with a median of $0.3990 per EA.

Are there cheaper alternatives to DILTIAZEM 24H ER(XR) 120 MG CP?

Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DILTIAZEM 24HR ER 120 MG CAP, is $0.0903 per EA — about 72% below DILTIAZEM 24H ER(XR) 120 MG CP.

Who manufactures DILTIAZEM 24H ER(XR) 120 MG CP?

DILTIAZEM 24H ER(XR) 120 MG CP (NDC 70436019101) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.